These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29162227)

  • 21. Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies.
    Sato S; Murakami A; Kuwajima A; Takehara K; Mimori T; Kawakami A; Mishima M; Suda T; Seishima M; Fujimoto M; Kuwana M
    PLoS One; 2016; 11(4):e0154285. PubMed ID: 27115353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three cases of autoimmune-associated haemophagocytic syndrome in dermatomyositis with anti-MDA5 autoantibody.
    Honda M; Moriyama M; Kondo M; Kumakura S; Sumita Y; Murakawa Y
    Scand J Rheumatol; 2020 May; 49(3):244-246. PubMed ID: 31571515
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease disguising as anti-synthetase syndrome.
    Tanaka N; Terao C; Nakayama Y; Sasai T; Umezawa N; Yagyu Y; Ito K; Koike R; Nakashima R; Hatta K; Mizoguchi F
    Rheumatology (Oxford); 2021 Mar; 60(3):e104-e106. PubMed ID: 33097938
    [No Abstract]   [Full Text] [Related]  

  • 24. Aberrant activation of the type I interferon system may contribute to the pathogenesis of anti-melanoma differentiation-associated gene 5 dermatomyositis.
    Zhang SH; Zhao Y; Xie QB; Jiang Y; Wu YK; Yan B
    Br J Dermatol; 2019 May; 180(5):1090-1098. PubMed ID: 29947075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharyngeal ulceration and perforation: a rare manifestation in anti-MDA5 dermatomyositis.
    Luo L; Huang W; Ren F; Zhou J; Huang D; Tang L
    Rheumatology (Oxford); 2021 Apr; 60(4):e132-e133. PubMed ID: 33197245
    [No Abstract]   [Full Text] [Related]  

  • 26. Unilateral heliotrope rash: a warning sign for anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.
    Kume M; Arase N; Okiyama N; Koguchi-Yoshioka H; Tada T; Saruban H; Fujimoto M
    Rheumatology (Oxford); 2021 Apr; 60(4):e134-e135. PubMed ID: 33197263
    [No Abstract]   [Full Text] [Related]  

  • 27. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.
    Merlo G; Clapasson A; Cozzani E; Sanna L; Pesce G; Bagnasco M; Burlando M; Parodi A
    Arch Dermatol Res; 2017 Mar; 309(2):87-95. PubMed ID: 27928683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Panniculitis as the initial manifestation of dermatomyositis with anti-MDA5 antibody.
    Hasegawa A; Shimomura Y; Kibune N; Koshio J; Umemori Y; Abe R
    Clin Exp Dermatol; 2017 Jul; 42(5):551-553. PubMed ID: 28543278
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-MDA5 antibody-positive dermatomyositis with lethal progressive interstitial lung disease and advanced gastric cancer.
    Yamaoka T; Doi C; Yokomi A; Tanemura A; Murota H; Tani M; Saruban H; Hamaguchi Y; Fujimoto M; Katayama I
    Eur J Dermatol; 2014; 24(4):490-1. PubMed ID: 25075604
    [No Abstract]   [Full Text] [Related]  

  • 30. Spontaneous pneumomediastinum in a dermatomyositis patient with anti-melanoma differentiation-associated gene-5 antibody and interstitial lung disease despite an initial response to immunosuppressant.
    Chan CWS; Chung HY; Lau CS; Tsang HHL
    Int J Rheum Dis; 2019 Mar; 22(3):521-524. PubMed ID: 28580698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis.
    Nishioka A; Tsunoda S; Abe T; Yoshikawa T; Takata M; Kitano M; Matsui K; Nakashima R; Hosono Y; Ohmura K; Mimori T; Sano H
    Mod Rheumatol; 2019 Sep; 29(5):814-820. PubMed ID: 30449228
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients.
    Fujiki Y; Kotani T; Isoda K; Ishida T; Shoda T; Yoshida S; Takeuchi T; Makino S
    Mod Rheumatol; 2018 Jan; 28(1):133-140. PubMed ID: 28490218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myositis-specific autoantibodies in dermatomyositis/polymyositis with interstitial lung disease.
    Li L; Wang H; Wang Q; Wu C; Liu C; Zhang Y; Cheng L; Zeng X; Zhang F; Li Y
    J Neurol Sci; 2019 Feb; 397():123-128. PubMed ID: 30616054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinically amyopathic dermatomyositis associated with anti-MDA5 antibody.
    Parperis K; Kiyani A
    BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29301801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of anti-CADM-140/MDA5 antibodies in a patient with classic dermatomyositis developing rapidly progressive interstitial lung disease.
    Miyake M; Sakai A; Nishijima C; Kita T; Nitta E; Kawashima A; Hamaguchi Y; Fujimoto M; Inaoki M
    J Dermatol; 2014 Jul; 41(7):664-5. PubMed ID: 24930560
    [No Abstract]   [Full Text] [Related]  

  • 36. Unilateral Eyelid Swelling as a Sign of Antimelanoma Differentiation-Associated Gene 5 (Anti-MDA5)-Antibody-Positive Dermatomyositis.
    Lam SC; Yuen HKL
    Ophthalmic Plast Reconstr Surg; 2018; 34(6):e209-e211. PubMed ID: 30365479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Severe MDA5 dermatomyositis associated with cancer and controlled by JAK inhibitor].
    Jalles C; Deroux A; Tardieu M; Lugosi M; Viel S; Benveniste O; Colombe B
    Rev Med Interne; 2020 Jun; 41(6):421-424. PubMed ID: 32192753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined immunosuppressive therapy provides favorable prognosis and increased risk of cytomegalovirus reactivation in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.
    Matsuda KM; Yoshizaki A; Kuzumi A; Fukasawa T; Ebata S; Yoshizaki-Ogawa A; Sato S
    J Dermatol; 2020 May; 47(5):483-489. PubMed ID: 32096271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of simultaneous onset of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis accompanied by interstitial pneumonia and pulmonary tuberculosis.
    Fujimoto S; Saito K; Kuwano K
    Int J Rheum Dis; 2020 Feb; 23(2):273-275. PubMed ID: 31916372
    [No Abstract]   [Full Text] [Related]  

  • 40. Association of Serum Soluble CD163 with Polymyositis and Dermatomyositis, Especially in Anti-MDA5 Antibody-positive Cases.
    Kawasumi H; Katsumata Y; Nishino A; Hirahara S; Kawaguchi Y; Kuwana M; Yamanaka H
    J Rheumatol; 2018 Jul; 45(7):947-955. PubMed ID: 29657141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.